Drawing for LIPIVIEW

USPTO serial 77384342

LIPIVIEW

Reviewed by CopyMark Law Group

Reg. 3917406Status 800Registered
Filing date
Status date
Registration date
Feb 8, 2011
Examiner
WILKE, JOHN
Law office
TMEG LAW OFFICE 104

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with LIPIVIEW?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and software, and parts and accessories therefor, for use with apparatus for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunctionACTIVEOct 15, 2010
010Medical apparatuses and devices, and parts and accessories therefor, used for analyzing [, diagnosing, treating, ] and monitoring eye disease, namely, dry eye and meibomian gland dysfunction;[ Medical device, and parts and accessories therefor, for expressing obstructions or occlusions from meibomian glands; Medical heater used primarily for medical purposes, namely, for applying heat to a patient's eye and related eye structure for treating eye diseases, namely, dry eye and meibomian gland dysfunction; Medical devices, namely, medical contact lens used primarily for medical purposes containing an electrical heating element for applying heat to meibomian glands when installed on a patient's eye for treating dry eye and meibomian gland dysfunction; ] Optical and photographic apparatus and instruments, and parts and accessories therefor, namely, interferometers and cameras, for analyzing, diagnosing, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; medical imaging apparatuses and devices comprising optical lens, camera, lamp, LED, spectrometer, used for analyzing, diagnosing, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction [ ; electronic medical temperature controller, and parts and accessories therefor, used primarily for temperature controller purposes, namely, for delivering and controlling heat to meibomian glands for use in treating eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical pressure controller, and parts and accessories therefor, used primarily for controlling pressure, namely, for applying and controlling pressure to the meibomian glands for use in treating eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical fluid transfer controller, and parts and accessories therefor, used primarily for controlling and transferring heated fluid to the eye for use in treating eye disease, namely, dry eye and meibomian gland dysfunction ]ACTIVEOct 15, 2010
016[ Printed instructional, educational and teaching materials in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Printed instructional, educational and teaching materials for analysis, diagnosis, treatment, and monitoring of eye disease, namely, dry eye and meibomian gland dysfunction ]SECTION 8 - CANCELLEDOct 15, 2010
041[ Education services, namely, classes, conferences, seminars, workshops, in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Education services, namely, providing seminars, tutorials, workshops for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; Training services in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Training services, namely, providing seminars, tutorials, workshops for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction ]SECTION 8 - CANCELLEDOct 15, 2010
044[ Medical services, namely, providing medical analysis, diagnosis, treatment, and monitoring of eye diseases and conditions; Medical services, namely, providing medical analysis, diagnosis, treatment, and monitoring of dry eye and meibomian gland dysfunction; ] Providing medical information related to eye disease, namely, dry eye and meibomian gland dysfunction, for educational purposesACTIVEOct 15, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2021NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
May 16, 2021RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
May 16, 20219G8PREGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
May 16, 20218PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
May 16, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 5, 2021E89RTEAS SECTION 8 & 9 RECEIVED
Feb 8, 2020REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 11, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 6, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 16, 2016NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 16, 2016C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 16, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 8, 2016E815TEAS SECTION 8 & 15 RECEIVED
Feb 8, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 6, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Jan 5, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED
Jan 4, 2011ALIEASSIGNED TO LIE
Dec 15, 2010CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 7, 2010SUPCSTATEMENT OF USE PROCESSING COMPLETE
Dec 2, 2010IUAFUSE AMENDMENT FILED
Dec 2, 2010EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 8, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jun 7, 2010EX3GSOU EXTENSION 3 GRANTED
Jun 2, 2010EXT3SOU EXTENSION 3 FILED
Jun 2, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 15, 2010EX2GSOU EXTENSION 2 GRANTED
Jan 14, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 24, 2009EXT2SOU EXTENSION 2 FILED
Nov 24, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2009DOCKASSIGNED TO EXAMINER
May 6, 2009EX1GSOU EXTENSION 1 GRANTED
May 6, 2009EXT1SOU EXTENSION 1 FILED
May 6, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 2, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 9, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 20, 2008NPUBNOTICE OF PUBLICATION
Aug 8, 2008CNEAEXAMINERS AMENDMENT MAILED
Aug 7, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 7, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 7, 2008XAECEXAMINER'S AMENDMENT ENTERED
Aug 7, 2008CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 4, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 1, 2008PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 21, 2008CNEAEXAMINERS AMENDMENT MAILED
Jul 18, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 18, 2008ALIEASSIGNED TO LIE
Jul 18, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2008XAECEXAMINER'S AMENDMENT ENTERED
Jul 18, 2008CNEAEXAMINERS AMENDMENT -WRITTEN
Jul 1, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 12, 2008CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2008DOCKASSIGNED TO EXAMINER
Feb 4, 2008NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance